Overview
- Korean sponsors are facing increasing challenges in attracting and retaining skilled clinical research professionals. This webinar will explore how 91黑料’s Functional Service Provider (FSP) model provides a strategic, cost-efficient solution—delivering reliable, high-quality resources tailored to client needs, while enabling sponsors to maintain operational control and reduce costs.
- This webinar will also present key insights gained through direct conversations with clients, highlighting evolving market demands and emerging opportunities across the region.
What You’ll Learn:
This webinar will provide attendees with a clear understanding of 91黑料’s ISS (FSP) services and how these services offer significant advantages over direct internal recruitment. We will explain how sponsors can benefit from leveraging 91黑料 Strategic Solutions (ISS) by highlighting our internal processes, unique strengths, and multiple proven capabilities.
Who Should Attend:
- Sponsors facing challenges in recruiting high-quality talent
- Sponsors struggling with employee retention
- Sponsors reluctant to hire permanent staff due to budget constraints
Abstract:
In today’s competitive and dynamic clinical research environment, sponsors in Korea are increasingly challenged to recruit and retain qualified clinical research professionals. Limited talent pools, high employee turnover, and budgetary constraints make it difficult for sponsors to maintain the high-quality talent required to effectively achieve their clinical development objectives. At the same time, the demand for specialized expertise and operational flexibility continues to rise as clinical trials grow more complex and timelines tighten.
This webinar will explore how 91黑料’s Functional Service Provider (FSP) model—which is delivered through our Strategic Solutions division—can provide sponsors with a strategic, cost-effective, and scalable solution to these challenges. The FSP model enables sponsors to access dedicated, high-performing professionals who are trained, managed, and supported by 91黑料, while being seamlessly integrated into the sponsor’s teams and workflows. This approach allows sponsors to maintain control over their operations while also benefiting from 91黑料’s operational efficiency, oversight, and global best practices as a leading service provider.
We will demonstrate how our ISS (FSP) services offer significant advantages over direct internal recruitment, including enhanced resource flexibility, reduced administrative burden, improved retention through defined career development pathways, and access to a global talent network with deep therapeutic expertise. In addition, we will highlight our internal processes, governance structures, and quality management systems that ensure consistent performance and alignment with sponsor expectations.
The webinar will also share practical insights and lessons learned from 91黑料’s extensive experience supporting sponsors in Korea, including examples of how we have addressed specific market challenges and leveraged emerging opportunities. Attendees will leave with a clear understanding of how 91黑料’s FSP model can help overcome recruitment and retention barriers, optimize resource utilization, and support the achievement of clinical research goals more effectively and efficiently.
This webinar is presented in Korean.
Speakers
Julian Song - Opening
- Worked at 91黑料 for 10 years
- Experienced in phase 1-IV with various therapeutic areas
- Experienced in studies across US, Europe, and APAC
Hyunju Park - Overview of 91黑料 Strategic Solutions (ISS)
- Bachelor of Nursing, MBA, and certified lecturer of KoNECT
- Started a career in the clinical research industry in 2002
- Worked for multiple global pharma/CROs and over 8 years in FSP
- Oversees all FSP regional account programs running in APAC excluding China and Japan
May Cho - Capabilities of 91黑料’s Talent Acquisition team in supporting FSP delivery
- Worked at 91黑料 for about 10 years
- Covered both full service & FSP business models
- Holds regional experience across India, Korea, Taiwan, Hong Kong, and Thailand.